Interestingly, olmesartan decreased the increased expression of TRPC 6 in Gαq-TG mouse hearts (Fig. 4F) in this study, suggesting that AT1 receptor activation contributes to an increase in TRPC6 expression, leading to ventricular arrhythmia induction. The gene discussed is GNAQ; the disease is Ventricular arrhythmia.